MedTrace Logo

Evaluation of Zotarolimus Eluting Stent at 3 Months Using Optical Coherence Tomography

NCT00815139 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2008-12-29

No results posted yet for this study

Summary

Neointimal coverage over stent strut is important for preventing the stent thrombosis. But, there is no data for the duration of complete formation of neointima om zotarolimus eluting stent (ZES). Previously the investigational observational data at 9 months showed most of stent strut was covered with neointima. Therefore, the investigators investigated the evaluation of neointimal coverage on 3 months after ZES implantation using novel OCT system, which is powerful intravascular imaging system having the higher resolution power.

Conditions

Sponsors & Collaborators

  • Yonsei University

    lead OTHER

Principal Investigators

  • Yangsoo Jang, MD, Ph D · Division of Cardiology, Cardiovascular Hospital, Yonsei University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-11-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00815139 on ClinicalTrials.gov